Danaher Corporation $DHR Shares Bought by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC grew its position in shares of Danaher Corporation (NYSE:DHR) by 36.6% during the 1st quarter, HoldingsChannel.com reports. The firm owned 11,204 shares of the conglomerate’s stock after buying an additional 3,004 shares during the quarter. Elevation Point Wealth Partners LLC’s holdings in Danaher were worth $2,129,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. JPL Wealth Management LLC purchased a new stake in Danaher in the 3rd quarter valued at $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the 4th quarter worth $26,000. WFA of San Diego LLC acquired a new position in Danaher in the second quarter valued at $26,000. Hilton Head Capital Partners LLC acquired a new position in Danaher in the fourth quarter valued at $27,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of several recent research reports. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Jefferies Financial Group reaffirmed a “buy” rating and set a $245.00 price objective on shares of Danaher in a research note on Tuesday, April 21st. The Goldman Sachs Group decreased their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. Barclays lowered their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Finally, HSBC cut their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Price Performance

Shares of NYSE:DHR opened at $197.85 on Monday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a 50-day moving average price of $179.01 and a 200 day moving average price of $200.34. The company has a market cap of $140.03 billion, a P/E ratio of 38.27, a PEG ratio of 2.52 and a beta of 0.79. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period last year, the firm earned $1.88 EPS. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. Research analysts predict that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.